These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36112984)

  • 21. Higher sexual interest with androgen receptor inhibitor monotherapy than with castration plus an androgen receptor inhibitor in prostate cancer patients treated with curative radiotherapy, but otherwise small health-related quality of life differences: A randomised prospective 18-month follow-up study.
    Majumder K; Nilsson S; Johansson H; Ullén A; Lennernäs B; Bergenmar M; Brandberg Y
    Eur J Cancer; 2016 Sep; 65():43-51. PubMed ID: 27459586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-Related Quality of Life Changes in Prostate Cancer Patients after Radical Prostatectomy: A Longitudinal Cohort Study.
    Shin DW; Lee SH; Kim TH; Yun SJ; Nam JK; Jeon SH; Park SC; Jung SI; Park JH; Park J
    Cancer Res Treat; 2019 Apr; 51(2):556-567. PubMed ID: 30011984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer-related symptoms predict psychological wellbeing among prostate cancer survivors: results from the PiCTure study.
    Sharp L; O'Leary E; Kinnear H; Gavin A; Drummond FJ
    Psychooncology; 2016 Mar; 25(3):282-91. PubMed ID: 26249170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients.
    Zahid N; Martins RS; Zahid W; Khalid W; Azam I; Bhamani SS; Asad N; Ahmad K; Jabbar AA; Shamim MS; Khan RJ; Javed G; Bari E; Enam SA
    J Patient Rep Outcomes; 2021 Sep; 5(1):79. PubMed ID: 34487251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Relugolix Versus Leuprolide on the Quality of Life of Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study.
    Tombal B; Collins S; Morgans AK; Hunsche E; Brown B; Zhu E; Bossi A; Shore N
    Eur Urol; 2023 Dec; 84(6):579-587. PubMed ID: 37833178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brachytherapy versus prostatectomy in localized prostate cancer: results of a French multicenter prospective medico-economic study.
    Buron C; Le Vu B; Cosset JM; Pommier P; Peiffert D; Delannes M; Flam T; Guerif S; Salem N; Chauveinc L; Livartowski A
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):812-22. PubMed ID: 17293235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychosocial and physical outcomes of in- and outpatient rehabilitation in prostate cancer patients treated with radical prostatectomy.
    Rath HM; Ullrich A; Otto U; Kerschgens C; Raida M; Hagen-Aukamp C; Koch U; Bergelt C
    Support Care Cancer; 2016 Jun; 24(6):2717-26. PubMed ID: 26803833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health-related quality of life in Dutch men with prostate cancer.
    Voerman B; Fischer M; Visser A; Garssen B; van Andel G; Bensing J
    J Psychosoc Oncol; 2006; 24(2):49-64. PubMed ID: 17046806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does palliative chemotherapy really palliate and are we measuring it correctly? A mixed methods longitudinal study of health related quality of life in advanced soft tissue sarcoma.
    Gough N; Koffman J; Ross JR; Riley J; Judson I
    PLoS One; 2019; 14(9):e0210731. PubMed ID: 31557183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normative data for the EORTC QLQ-C30 from the Austrian general population.
    Lehmann J; Giesinger JM; Nolte S; Sztankay M; Wintner LM; Liegl G; Rose M; Holzner B;
    Health Qual Life Outcomes; 2020 Aug; 18(1):275. PubMed ID: 32787854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term health-related quality of life after curative treatment for prostate cancer: a regional cross-sectional comparison of two standard treatment modalities.
    Hjälm-Eriksson M; Lennernäs B; Ullén A; Johansson H; Hugosson J; Nilsson S; Brandberg Y
    Int J Oncol; 2015 Jan; 46(1):381-8. PubMed ID: 25355465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the occurrence of a response shift on the determination of the minimal important difference in a health-related quality of life score over time.
    Ousmen A; Conroy T; Guillemin F; Velten M; Jolly D; Mercier M; Causeret S; Cuisenier J; Graesslin O; Hamidou Z; Bonnetain F; Anota A
    Health Qual Life Outcomes; 2016 Dec; 14(1):167. PubMed ID: 27914467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association of depressive symptoms, personality traits, and sociodemographic factors with health-related quality of life and quality of life in patients with advanced-stage lung cancer: an observational multi-center cohort study.
    de Mol M; Visser S; Aerts J; Lodder P; van Walree N; Belderbos H; den Oudsten B
    BMC Cancer; 2020 May; 20(1):431. PubMed ID: 32423432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of acute urinary retention after iodine-125 prostate brachytherapy on health-related quality of life.
    Roeloffzen EM; Hinnen KA; Battermann JJ; Monninkhof EM; van Roermund JG; van Gellekom MP; Frank SJ; van Vulpen M
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1322-8. PubMed ID: 19939578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Postoperative Adjuvant Radiotherapy on Quality of Life, Anxiety, and Depression in Adult Female Breast Cancer Patients.
    Parvizi M; Kut E; Akyol M; Ay S
    Cureus; 2023 Mar; 15(3):e36635. PubMed ID: 36968677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management and health-related quality of life among patients with prostate cancer in a Kenyan tertiary health facility.
    Karaihira W; Karimi PN; Weru IW
    J Oncol Pharm Pract; 2023 Dec; ():10781552231221110. PubMed ID: 38105481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychometric evaluation of the Taiwan Chinese version of the EORTC QLQ-PR25 for HRQOL assessment in prostate cancer patients.
    Chang YJ; Liang WM; Wu HC; Lin HC; Wang JY; Li TC; Yeh YC; Chang CH
    Health Qual Life Outcomes; 2012 Aug; 10():96. PubMed ID: 22901052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between Geriatric 8 frailty and health-related quality of life in older patients with cancer (PROGNOSIS-G8): a Danish single-centre, prospective cohort study.
    Ditzel HM; Giger AW; Lund CM; Ditzel HJ; Möller S; Pfeiffer P; Ryg J; Ewertz M; Jørgensen TL
    Lancet Healthy Longev; 2024 Sep; 5(9):100612. PubMed ID: 39217995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigating the psychological impact of active surveillance or active treatment in newly diagnosed favorable-risk prostate cancer patients: A 9-month longitudinal study.
    Ruane-McAteer E; Porter S; O'Sullivan J; Dempster M; Prue G
    Psychooncology; 2019 Aug; 28(8):1743-1752. PubMed ID: 31243872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.